Microalbuminuria in IDDM is associated with increased expression of monocyte procoagulant activity.
Microalbuminuria, the early phase of diabetic nephropathy, is associated with an increased risk of atherothrombosis. Monocytes play an important part in the pathogenesis of atherosclerosis and in the activation of haemostasis. However, procoagulant activity is poorly understood in Type I (insulin-dependent) diabetes mellitus, particularly in the presence of microalbuminuria. This study aimed to evaluate spontaneous and endotoxin-induced monocyte procoagulant activity in insulin-dependent diabetic patients with normoalbuminuria or microalbuminuria. Seventeen patients with microalbuminuria, 28 with normoalbuminuria and 26 healthy control subjects matched for age, sex, body mass index and smoking habit were studied. Mononuclear cells from peripheral venous blood were incubated with or without bacterial lypopolysaccharide. Spontaneous procoagulant activity and procoagulant activity after 3 h and 6 h of incubation were calculated. Spontaneous procoagulant activity values were similar in the three groups. After 3 h and 6 h incubation with bacterial lypopolysaccharide, procoagulant activity values were slightly, but not statistically significantly, higher in the normoalbuminuric diabetic group than in control group, and significantly higher in microalbuminuric diabetic group than in control group (p < 0.01). The increased endotoxin-induced monocyte procoagulant activity helps to explain the link between microalbuminuria and the increased risk of atherothrombosis in patients with Type I diabetes.
Bazzan
M
M
Department of Haematology and Onco-Haematology, University of Turin, Italy.
Gruden
G
G
Stella
S
S
Vaccarino
A
A
Tamponi
G
G
Olivetti
C
C
Giunti
S
S
Cavallo-Perin
P
P
D000328:Adult; D000419:Albuminuria; D000704:Analysis of Variance; D001161:Arteriosclerosis / Q000453:epidemiology; D001777:Blood Coagulation / Q000187:drug effects; D001794:Blood Pressure; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000652:urine*; D003925:Diabetic Angiopathies / Q000453:epidemiology; D004731:Endotoxins / Q000494:pharmacology; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D008070:Lipopolysaccharides / Q000494:pharmacology; D008297:Male; D009000:Monocytes / Q000187:drug effects / Q000502:physiology*; D012016:Reference Values; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood
D002784:Cholesterol; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D004731:Endotoxins; D006442:Glycated Hemoglobin; D008070:Lipopolysaccharides; D014280:Triglycerides